Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides access to approximately 17 million additional ...

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides access to approximately 17 million additional U.S. commercial lives (10% of the ~177 million commerc ...

Novel disorder causing severe respiratory dysfunction linked to loss-of-function gene variant

A new report in the American Journal of Human Genetics describes a novel disorder caused by biallelic loss-of-function ...
Psychology Today

Is It ADHD, or Are We Scrolling too Fast…?

As ADHD diagnoses and self-diagnoses continue to rise, one question remains unexplored: What role does technology play in how ...